Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Changing fortunes: is Biotech giant CSL’s $10 billion write-down a comeback story?

Make no mistake: the home-grown biotechnology company, which for decades allowed Australia serious boasting rights, is still a long way from redemption.

Changing fortunes: is Biotech giant CSL’s $10 billion write-down a comeback story?

We haven't written up this one. The Sydney Morning Herald has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at smh.com.au →

More in Finance & Markets

Bursa Malaysia stays higher at midday

KUALA LUMPUR: Bursa Malaysia remained positive at midday, supported by buying interest in selected heavyweights, particularly in the plantation, industrial products and services, as well as financial…

More from Tuesday 18 August →